PUBLISHER: The Business Research Company | PRODUCT CODE: 1945330
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945330
Hydrophilic angiographic catheters are specialized catheters used in radiology and cardiology that feature a hydrophilic coating to reduce friction, allowing smoother navigation through complex blood vessels during diagnostic and therapeutic procedures.
The main types of hydrophilic angiographic catheters include selective angiographic catheters and non-selective angiographic catheters. Selective angiographic catheters are engineered to provide targeted access to specific blood vessels and feature various tip shapes and curves to navigate complex vascular structures and engage vessel openings. These devices are used in applications such as cardiac disease treatment, renal disease treatment, and others by end users including hospitals, diagnostic imaging centers, and others.
Tariffs are impacting the hydrophilic angiographic catheters market by increasing costs for imported raw materials, coatings, and precision manufacturing components. These impacts are most visible in selective catheter segments and in regions such as Asia-Pacific and Europe, where cross-border sourcing is common. Higher duties have led to increased device prices and margin pressure for manufacturers. However, tariffs are also encouraging localized production, supplier diversification, and innovation in cost-efficient catheter designs, supporting long-term market stability.
The hydrophilic angiographic catheters market research report is one of a series of new reports from The Business Research Company that provides hydrophilic angiographic catheters market statistics, including hydrophilic angiographic catheters industry global market size, regional shares, competitors with a hydrophilic angiographic catheters market share, detailed hydrophilic angiographic catheters market segments, market trends and opportunities, and any further data you may need to thrive in the hydrophilic angiographic catheters industry. This hydrophilic angiographic catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hydrophilic angiographic catheters market size has grown strongly in recent years. It will grow from $13.54 billion in 2025 to $14.55 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to growing prevalence of cardiovascular diseases, expansion of diagnostic angiography procedures, reliance on conventional angiographic catheters, increasing hospital-based interventional procedures, advancements in catheter material science.
The hydrophilic angiographic catheters market size is expected to see strong growth in the next few years. It will grow to $19.13 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to rising demand for minimally invasive interventions, technological innovation in hydrophilic coating technologies, growth in interventional cardiology and radiology, increasing healthcare expenditure on cardiac care, expanding access to advanced imaging and catheterization labs. Major trends in the forecast period include increasing use of hydrophilic coatings for reduced friction, rising adoption in minimally invasive cardiovascular procedures, growing preference for selective angiographic catheters, improved catheter trackability in complex vascular anatomy, enhanced focus on procedural safety and physician control.
The growth in the prevalence of renal disorders is increasingly supporting the expansion of the hydrophilic angiographic catheters market going forward. Renal disorders encompass a wide range of conditions that impair kidney function, including blood filtration, waste elimination, fluid balance, and blood pressure regulation. The rising prevalence of renal disorders is primarily associated with increasing rates of diabetes, hypertension, and aging populations. Hydrophilic angiographic catheters are used in renal disorder management to enable smooth and precise navigation during diagnostic and interventional procedures such as renal angiography and stenting. For example, in June 2023, according to Kidney Research UK, approximately 7.2 million people in the UK were living with chronic kidney disease, representing over 10% of the population, with projections indicating growth to 7.61 million by 2033. Consequently, the expanding prevalence of renal disorders is reinforcing growth in the hydrophilic angiographic catheters market.
Leading companies operating in the hydrophilic angiographic catheters market are focusing on developing innovative products such as catheters with multiple curve configurations to maintain their market position. Catheters with various curve configurations are engineered to navigate complex vascular anatomy more effectively. For example, in January 2024, Cook Group Incorporated, a US-based medical device company, launched the Slip-Cath Beacon Tip hydrophilic selective catheter in the US and Canada. The catheter offers more than 30 curve options, protective foil packaging for extended durability, and a three-year shelf life, enhancing procedural flexibility and compatibility with a wide range of vascular access devices.
In April 2024, Shenzhen Mindray Technology Holdings Co. Ltd., a China-based medical device company, acquired a 19.72% stake in APT Medical for $927 million. This acquisition positions Mindray as a significant participant in the cardiovascular medical device market, enabling it to leverage APT Medical's expertise in cardiac electrophysiology and vascular intervention technologies. APT Medical is a China-based medical device company specializing in hydrophilic angiographic catheters.
Major companies operating in the hydrophilic angiographic catheters market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Cook Medical Inc., Teleflex Incorporated, Lepu Medical Technology (Beijing) Co Ltd., Merit Medical Systems Inc., Cordis Corporation, MicroPort Scientific Corporation, Asahi Intecc Co Ltd., AngioDynamics Inc., Alvimedica Medical Technologies, BrosMed Medical Co Ltd., iVascular SLU, Hexacath, Invamed Group
Asia-Pacific was the largest region in the hydrophilic angiographic catheters market in 2025. The regions covered in the hydrophilic angiographic catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the hydrophilic angiographic catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The hydrophilic angiographic catheters market consists of sales of guidewire, imaging equipment, contrast media injectors, and control and steering devices. The market value includes the value of related goods sold by the service provider or included within the service offering. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Hydrophilic Angiographic Catheters Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses hydrophilic angiographic catheters market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for hydrophilic angiographic catheters ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hydrophilic angiographic catheters market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.